Impaired HVJ-stimulated Interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
12 2020
Historique:
received: 01 08 2019
revised: 20 07 2020
accepted: 22 07 2020
pubmed: 23 8 2020
medline: 27 11 2021
entrez: 23 8 2020
Statut: ppublish

Résumé

ANCA-associated RPGN leads to renal failure through systemic vasculitis and diffuse crescentic glomerulonephritis. MPO-ANCA-RPGN patients are highly susceptible to infections. Our aim in this study was to uncover reasons why these patients were susceptible to infections. We analyzed various aspects of type I interferon system including HVJ-stimulated IFN-α producing capacity and plasmacytoid dendritic cell (pDC) number in whole blood in MPO-ANCA-RPGN patients. Compared with healthy subjects, MPO-ANCA-RPGN patients showed impaired HVJ-stimulated IFN-α producing capacity and lower pDC number with or without glucocorticoid treatment. Immuno-histological staining of MPO-ANCA-RPGN kidney samples revealed a few but apparent pDC in T cell infiltrating regions even in patients with low pDC number in their peripheral blood. Patients' low HVJ-stimulated IFN-α producing capacity and pDC numbers persisted even after patients underwent several years of treatment. Former infection was determined using patients' serum BPI, Lamp-2 and Calprotectin, since they are reflective of a history of infection. These markers were higher in MPO-ANCA-RPGN patients than in healthy subjects. These results indicate that impaired HVJ-stimulated IFN-α production as well as dysfunction of the IFN system might have resulted from a previous bout of infection and can be partially implicated in patients' long-term susceptibility and vulnerability to infection.

Identifiants

pubmed: 32828064
pii: S1043-4666(20)30237-4
doi: 10.1016/j.cyto.2020.155221
pii:
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0
Interferon-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

155221

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kazuko Uno (K)

Louis Pasteur Center for Medical Research, Division of Basic Research, 103-5, Tanaka-Monzen cho, Sakyoku, Kyoto 606-8225, Japan. Electronic address: kazukouno@louis-pasteur.or.jp.

Eri Muso (E)

Division of Nephrology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20, Ogimachi, Kitaku, Osaka 530-8480, Japan; Department of Food and Nutrition Faculty of Contemporary Home Economics, Kyoto Kacho University, 3-456 Rinkacho, Higashiyama-ku, Kyoto 605-0062, Japan. Electronic address: emuso@kki.biglobe.ne.jp.

Toshiko Ito-Ihara (T)

The Clinical and Translational Research Center, University Hospital, Kyoto Prefectural University of Medicine, 456 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan. Electronic address: t-ihara@koto.kpu-m.ac.jp.

Tomomi Endo (T)

Division of Nephrology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20, Ogimachi, Kitaku, Osaka 530-8480, Japan. Electronic address: tsujiit@kuhp.kyoto-u.ac.jp.

Yuko Yasuda (Y)

Louis Pasteur Center for Medical Research, Division of Basic Research, 103-5, Tanaka-Monzen cho, Sakyoku, Kyoto 606-8225, Japan. Electronic address: yyasuda@louis-pasteur.or.jp.

Katusmi Yagi (K)

Louis Pasteur Center for Medical Research, Division of Basic Research, 103-5, Tanaka-Monzen cho, Sakyoku, Kyoto 606-8225, Japan. Electronic address: ktsmyg@yahoo.co.jp.

Kazuo Suzuki (K)

Department of Immunobiology, Inflammation Program, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba-city, Chiba 260-8670, Japan; Asia International Institute of Infectious Disease Control, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan. Electronic address: suzuki-k@med.teikyo-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH